Development of ctDNA for MRD detection in breast cancer

被引：0
|
作者：
Ozaki, Y. [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Adv Med Dev, Dept Breast Med Oncol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.691
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY26-2
引用
收藏
页码：S1296 / S1296
页数：1
相关论文
共 50 条
  • [21] SentryDX MRD Detection Platform from ctDNA Achieves Extreme Sensitivity and Low Cost
    Atkins, P.
    Nelson, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S165 - S165
  • [22] Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection
    Abbosh, Christopher
    Birkbak, Nicolai J.
    Swanton, Charles
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (09) : 577 - 586
  • [23] Clinical application and prospect of MRD evaluation in lung cancer based on ctDNA level: A review
    Yan, Xing
    Liu, Changhong
    TUMORI JOURNAL, 2023, 109 (04): : 356 - 362
  • [24] Circulating tumor DNA (ctDNA) for detection of molecular residual disease (MoRD) in breast cancer
    Austin, L.
    Jaslow, R.
    Fortina, P.
    Nagy, R.
    Zill, O.
    Talasaz, A.
    Cristofanilli, M.
    CANCER RESEARCH, 2016, 76
  • [25] ctDNA detection in seven different types of body liquids in patients with metastatic breast cancer
    Richard, Francois
    Geukens, Tatjana
    De Schepper, Maxim
    Mahdami, Amena
    Van Baelen, Karen
    Maetens, Marion
    Nguyen, Ha-Linh
    Pabba, Anirudh
    Leduc, Sophia
    Isnaldi, Edoardo
    Hajipirloo, Maysam
    Berghe, Emily Vanden
    Bachir, Imane
    Hatse, Sigrid
    Vermeulen, Peter
    Vanderheyden, Evy
    Boeckx, Bram
    Lambrechts, Diether
    Smeets, Ann
    Nevelsteen, Ines
    Punie, Kevin
    Neven, Patrick
    Wildiers, Hans
    Van Den Bogaert, Wouter
    Biganzoli, Elia
    Floris, Giuseppe
    CANCER RESEARCH, 2023, 83 (05)
  • [26] Increased blood draws for ultrasensitive ctDNA and CTCs detection in early breast cancer patients
    Alba-Bernal, Alfonso
    Godoy-Ortiz, Ana
    Dominguez-Recio, Maria Emilia
    Lopez-Lopez, Esperanza
    Quiros-Ortega, Maria Elena
    Sanchez-Martin, Victoria
    Roldan-Diaz, Maria Dunia
    Jimenez-Rodriguez, Begona
    Peralta-Linero, Jesus
    Bellagarza-Garcia, Estefania
    Troyano-Ramos, Laura
    Garrido-Ruiz, Guadalupe
    Hierro-Martin, M. Isabel
    Vicioso, Luis
    Gonzalez-Ortiz, Alvaro
    Linares-Valencia, Noelia
    Velasco-Suelto, Jesus
    Carbajosa, Guillermo
    Garrido-Aranda, Alicia
    Lavado-Valenzuela, Rocio
    Alvarez, Martina
    Pascual, Javier
    Comino-Mendez, Inaki
    Alba, Emilio
    NPJ BREAST CANCER, 2024, 10 (01)
  • [27] Discerning the impact of ctDNA detection on patient decisions in early-stage breast cancer
    Ballinger, Tarah
    Zimet, Gregory
    Railey, Elda
    Smith, Mary Lou
    Schneider, Bryan
    CANCER RESEARCH, 2024, 84 (09)
  • [28] Dual ctDNA and tissue sequencing improves detection of actionable variants in breast cancer patients
    Mackay, Matthew
    Manghnani, Kabir
    Hockenberry, Adam
    Drews, Joshua
    Chen, James
    Ben-Shachar, Rotem
    Guinney, Justin
    CANCER RESEARCH, 2023, 83 (05)
  • [29] Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
    Re-I Chin
    Kevin Chen
    Abul Usmani
    Chanelle Chua
    Peter K. Harris
    Michael S. Binkley
    Tej D. Azad
    Jonathan C. Dudley
    Aadel A. Chaudhuri
    Molecular Diagnosis & Therapy, 2019, 23 : 311 - 331
  • [30] Detection of Solid Tumor Molecular Residual Disease(MRD) Using Circulating Tumor DNA (ctDNA)
    Chin, Re-I
    Chen, Kevin
    Usmani, Abul
    Chua, Chanelle
    Harris, Peter K.
    Binkley, Michael S.
    Azad, Tej D.
    Dudley, Jonathan C.
    Chaudhuri, Aadel A.
    MOLECULAR DIAGNOSIS & THERAPY, 2019, 23 (03) : 311 - 331
12345